Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 18:14:1216457.
doi: 10.3389/fimmu.2023.1216457. eCollection 2023.

COVID, complement, and the brain

Affiliations
Review

COVID, complement, and the brain

Sonia I Vlaicu et al. Front Immunol. .

Abstract

The brains of COVID-19 patients are affected by the SARS-CoV-2 virus, and these effects may contribute to several COVID-19 sequelae, including cognitive dysfunction (termed "long COVID" by some researchers). Recent advances concerning the role of neuroinflammation and the consequences for brain function are reviewed in this manuscript. Studies have shown that respiratory SARS-CoV-2 infection in mice and humans is associated with selective microglial reactivity in the white matter, persistently impaired hippocampal neurogenesis, a decrease in the number of oligodendrocytes, and myelin loss. Brain MRI studies have revealed a greater reduction in grey matter thickness in the orbitofrontal cortex and parahippocampal gyrus, associated with a greater reduction in global brain size, in those with SARS-CoV-2 and a greater cognitive decline. COVID-19 can directly infect endothelial cells of the brain, potentially promoting clot formation and stroke; complement C3 seems to play a major role in this process. As compared to controls, the brain tissue of patients who died from COVID-19 have shown a significant increase in the extravasation of fibrinogen, indicating leakage in the blood-brain barrier; furthermore, recent studies have documented the presence of IgG, IgM, C1q, C4d, and C5b-9 deposits in the brain tissue of COVID-19 patients. These data suggest an activation of the classical complement pathway and an immune-mediated injury to the endothelial cells. These findings implicate both the classical and alternative complement pathways, and they indicate that C3b and the C5b-9 terminal complement complex (membrane attack complex, MAC) are acting in concert with neuroinflammatory and immune factors to contribute to the neurological sequelae seen in patients with COVID.

Keywords: C5b-9; COVID; brain; cognitive dysfunction; complement system; endothelial cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
SARS-CoV-2 and complement activation effect on brain endothelial cells. Immunoglobulins raised after SARS-CoV-2 infection can have direct effects on cells, but also indirect effects as shown by the activation of the complement system. All three activation pathways (classical, alternative and lectin) can be activated by the virus and lead to the formation of C3 convertase and C5 convertase. The formation of the terminal complement complex C5b-9 leads to the EC lysis or activation. Insertion of sublytic C5b-9 on EC lead to the activation of cell signaling pathways important in cell proliferation (ERK1 and PI3K pathway), the release of growth factors (PDGF, bFGF, PIGF) and cytokines (IL-1, IL-6, IL-8, MCP1). Subsequent to EC activation and lysis the infiltration of macrophages and T cells occurs, followed by activation of astrocytes and microglia and leakage of plasma proteins as a consequence of BBB changes and subsequent neuronal dysfunction. All these changes lead to brain dysfunction seen in long COVID syndrome (Created with BioRender.com).

References

    1. Monje M, Iwasaki A. The neurobiology of long COVID. Neuron (2022) 110(21):3484–96. doi: 10.1016/j.neuron.2022.10.006 - DOI - PMC - PubMed
    1. Perrottelli A, Sansone N, Giordano GM, Caporusso E, Giuliani L, Melillo A, et al. Cognitive impairment after post-acute COVID-19 infection: a systematic review of the literature. J Pers Med (2022) 12(12):2070. doi: 10.3390/jpm12122070 - DOI - PMC - PubMed
    1. Venkataramani V, Winkler F. Cognitive deficits in long covid-19. N Engl J Med (2022) 387(19):1813–5. doi: 10.1056/NEJMcibr2210069 - DOI - PubMed
    1. Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med (2022) 28(11):2406–15. doi: 10.1038/s41591-022-02001-z - DOI - PMC - PubMed
    1. Schulte E. Untangling genetic risk factors of long COVID: work of the international COVID-10 host genetics initiative. Eur Neuropsychopharmacol (2022) 63:e82. doi: 10.1016/j.euroneuro.2022.07.155 - DOI

Publication types

Substances